|
Initial reporter name and address: (b)(6).The complaint investigation for false elevated result for one patient when tested with the architect total b-hcg assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, field data review and in-house testing of retained kits with the complaint lot number.Return testing was not completed as returns were not available.Trending review determined no trends identified for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot.The overall performance of architect total b-hcg reagents in the field was reviewed using data gathered via customers worldwide and determined that the performance of the lot is acceptable.In-house testing was performed with retained kit lots of the complaint lot number 21034ui00 and determined that the specificity performance is not negatively impacted.Labeling was reviewed and adequately addresses the issue under review.Based on the investigation, no systemic issue or deficiency with the architect total b-hcg reagent lot 21034ui00 was identified.
|